All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

Equipping Healthcare Professionals with the Necessary Tools for Improving Care in Ovarian Cancer

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.


Confronting Inequities in Immuno-Oncology Care

Thursday, June 9, 2022, 5:30 PM - 6:30 PM ET
  -  Register



Activity Description

This program is a 1-hour, ACPE-accredited, live virtual satellite symposium at the 2022 Academy of Managed Care Pharmacy (AMCP) Health Disparities Summit that is designed to educate HCPs on the latest evidence-based cancer immunotherapy treatment and immune-related AE (irAE) management and to increase awareness of and provide educational resources and training to recognize and address cancer health disparities based on specific drivers of inequity, including racial, socioeconomic, sex, gender identity, and geography.

Target Audience

The target audience for this activity is pharmacists, including managed care, specialty, and clinical pharmacists, who care for patients with cancer as well as pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Identify patient populations and social determinants of health that increase risk for poor prognosis secondary to health disparities.
  • Discuss management of immune-related adverse events in patient groups affected by inequalities and poor healthcare access.
  • Incorporate health disparity mitigation strategies into the care of all patients receiving immune checkpoint inhibitor therapy and experiencing immune-related adverse events.
  • Describe education, quality improvement, and other support strategies to ensure patients with cancer receive optimal and equitable care.


Jessica Michaud Davis, PharmD, BCOP, CPP
Clinical Pharmacist Coordinator, Adult Hematology/Oncology
Levine Cancer Institute
Charlotte, North Carolina

Kamakshi V. Rao, PharmD, BCOP, FASHP
Assistant Director
Department of Pharmacy
University of North Carolina Medical Center
Adjunct Professor of Clinical Education
Division of Practice Advancement and Clinical Education
UNC Eshelman School of Pharmacy
Chapel Hill, North Carolina

CE Accreditation


ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-22-187-L01-P has been assigned to this live application-based activity (initial release date 6-9-22). This activity is approved for 1.0 contact hours (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at, and proof of completion will be posted in NABP CPE Monitor profiles.


ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Faculty disclosures will be provided prior to the start of the CE activity.


This activity is supported by educational grants from Bristol Myers Squibb and Merck Sharp & Dohme Corp.


The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.